Michelle L Tas
4PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 13, 2021
Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis.Michelle L Tas, Lisa W Dootjes, Marta Fiocco
|Apr 30, 2021
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma.Celina L Szanto, Annelisa M Cornel, Sara M Tamminga
|Feb 06, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.Gerda Kildisiute, Waleed M Kholosy, Matthew D Young
|Nov 19, 2019
Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.Michelle L Tas, Michelle Nagtegaal, Kathelijne C J M Kraal
Pageof 1
Frequent Collaborators
2 joint publications
Kathelijne C J M Kraal
2 joint publications
Jan J Molenaar
1 joint publications
Michelle Nagtegaal
1 joint publications
Godelieve A M Tytgat
1 joint publications
Jan Koster
1 joint publications
Saskia M F Pluijm
1 joint publications
C Michel Zwaan
1 joint publications
Bart de Keizer
1 joint publications
Max M van Noesel
1 joint publications
Gerda Kildisiute
